Leon Homero Hernandez Gets 7 Years for Drug Trafficking

Leon Homero Hernandez, a 42-year-old U.S. citizen living in Mexico, is going to prison for trafficking methamphetamine and cocaine across the border into New Mexico. The feds came down hard, sentencing Hernandez to 84 months behind bars followed by four years of supervised release after his guilty plea in federal court in Las Cruces.

Hernandez was arrested on October 28, 2015, after a four-count indictment charged him with distributing cocaine on August 17 and September 2, 2015, and methamphetamine on September 2 and September 23 of the same year. All transactions occurred in Dona Ana County, a known corridor for drug movement between Mexico and the U.S. interior.

The evidence was cut-and-dry: undercover law enforcement agents bought drugs directly from Hernandez during multiple controlled buys. He admitted to selling 24.1 grams of cocaine on August 17, then 23.8 grams of cocaine and 27.3 grams of pure meth on September 2. His final sale, on September 23, was 56.6 grams of pure methamphetamine—escalating both in volume and risk.

On March 10, 2016, Hernandez pleaded guilty to a felony information consolidating the charges—two counts of distributing cocaine, two of methamphetamine. By admitting guilt, he avoided trial but locked in a federal prison term that reflects the seriousness of cross-border drug operations in the Southwest.

As part of the judgment, Hernandez was also ordered to forfeit $3,900 to the United States—a fraction of the profits, investigators say, but a symbolic clawback in a case built on hard evidence and undercover work. The money, likely tied to drug proceeds, was seized as part of the broader forfeiture provisions in the original indictment.

The case was investigated by the Drug Enforcement Administration’s Las Cruces office, a frontline unit in the federal fight against cartel-linked trafficking. Assistant U.S. Attorney Terri J. Abernathy, based in the Las Cruces branch, handled the prosecution, pushing for accountability in a region where drug networks operate with brazen precision.